Add to ORKGCopyright © 2014 Meng-Hwan Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Production of biopharmaceuticals from transgenic animal milk is a cost-effective method for highly complex proteins that cannot be efficiently produced using conventional systems such as microorganisms or animal cells. Yields of recombinant human factor IX (rhFIX) produced from transgenic porcine milk under the control of the bovin
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Among all the transgenic mammalians produced so far, goats have represented an excellent model of tr...
Introduction: In this review, the analysis of technologies for obtaining biologically active protein...
Production of biopharmaceuticals from transgenic animal milk is a cost-effective method for highly c...
Hemophilia B is the congenital bleeding disorder caused by deficiency in functional coagulation fact...
Hemophilia B is the congenital bleeding disorder caused by deficiency in functional coagulation fact...
Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the mi...
Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the mi...
Human factor IX is synthesized in the liver and secreted in the blood, where it participates in a gr...
A non-human transgenic mammalian animal, as described above, contains an exogenous double stranded D...
Both the low animal cell density of bioreactors and their ability to post-translationally process re...
Haemophilia replacement factors, both plasma-derived and recombinant, are in relatively short supply...
Expression of active human factor IX in mammary tissue and of milk non human transgenic mammal
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Hemophilia B is a genetic disease of the coagulation system that affects one in 30,000 males worldwi...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Among all the transgenic mammalians produced so far, goats have represented an excellent model of tr...
Introduction: In this review, the analysis of technologies for obtaining biologically active protein...
Production of biopharmaceuticals from transgenic animal milk is a cost-effective method for highly c...
Hemophilia B is the congenital bleeding disorder caused by deficiency in functional coagulation fact...
Hemophilia B is the congenital bleeding disorder caused by deficiency in functional coagulation fact...
Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the mi...
Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the mi...
Human factor IX is synthesized in the liver and secreted in the blood, where it participates in a gr...
A non-human transgenic mammalian animal, as described above, contains an exogenous double stranded D...
Both the low animal cell density of bioreactors and their ability to post-translationally process re...
Haemophilia replacement factors, both plasma-derived and recombinant, are in relatively short supply...
Expression of active human factor IX in mammary tissue and of milk non human transgenic mammal
This is an Open Access article distributed under the terms of the Creative Commons Attribution Licen...
Hemophilia B is a genetic disease of the coagulation system that affects one in 30,000 males worldwi...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Among all the transgenic mammalians produced so far, goats have represented an excellent model of tr...
Introduction: In this review, the analysis of technologies for obtaining biologically active protein...